Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05281042 · ClinicalTrials.gov registry record
Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study
A clinical trial, sponsored by Notal Vision.
- Completed
- Registry status
- 20
- Enrollment target
NCT05281042 is a clinical trial that has completed, run by Notal Vision. The registered enrollment target is 20 participants.
The verdict
NCT05281042 has completed, sponsored by Notal Vision.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The study will enroll up to 30 AMD patients diagnosed with NV-AMD in at least one eye at the time of enrollment. At the Study Visit, fluid must be present in at least one eye of the subjects. If only one eye qualifies for enrollment, that will be assigned as the study eye. If both eyes are eligible, the study eye will be assigned according to a randomization schedule. Only one eye of each subject will be enrolled in the study. All subjects will be enrolled at 1 site in the United States. Subjects must meet all inclusion and no exclusion criteria.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2022-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05281042
The ClinicalTrials.gov registry entry for NCT05281042 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Notal Vision, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05281042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05281042 about?
NCT05281042 is a clinical study titled "Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study". The study will enroll up to 30 AMD patients diagnosed with NV-AMD in at least one eye at the time of enrollment. At the Study Visit, fluid must be present in at least one eye of the subjects. If only one eye qualifies for enrollment, that will be assigned as the study eye. If both eyes are eligible,...
What is the current status of trial NCT05281042?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-09-13. Estimated completion is 2022-01-05.
Who is sponsoring clinical trial NCT05281042?
This trial is sponsored by Notal Vision, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.